腹腔镜与机器人经肛微创手术治疗直肠肿瘤的短期结局与成本比较
单中心回顾性研究纳入40例直肠肿瘤患者,比较腹腔镜经肛微创手术(L-TAMIS)与机器人经肛微创手术(R-TAMIS)的短期结局和成本。R-TAMIS手术直接成本中位数显著更高(4440.92美元 vs 3562美元,p=0.04),但两组死亡率均为0%,其他结局无显著差异。
要点
- R-TAMIS手术直接成本中位数较L-TAMIS高880美元(4440.92 vs 3562美元,p=0.04)。
- 两组死亡率均为0%,R-TAMIS组出血量有减少趋势。
- L-TAMIS手术总时长范围更宽,可能与体型和肿瘤位置变异有关。
核心结论
- L-TAMIS与R-TAMIS在短期结局上无显著差异,仅总直接成本存在显著差异。
- 两种术式均安全且并发症发生率低。
研究设计与样本
- 单中心回顾性研究,分析前瞻性维护数据库,纳入2012年1月至2017年4月由两位结直肠外科医生连续治疗的40例直肠肿瘤患者。
主要发现
- R-TAMIS手术直接成本中位数显著高于L-TAMIS(4440.92美元 vs 3562美元,p=0.04),增加880美元。
- 两组患者 demographics 无显著差异。
- R-TAMIS组出血量有减少趋势。
- 两组死亡率均为0%。
- L-TAMIS手术总时长范围更宽,可能因体型和直肠肿瘤位置变异限制L-TAMIS。
临床怎么用
- 在追求更低成本时可优先考虑L-TAMIS,但需考虑肿瘤位置和体型对操作的影响。
- R-TAMIS可能为复杂病例提供更稳定的平台和更灵活的操作。
局限性
- 样本量小(40例)。
- 回顾性研究设计。
- 缺乏长期肿瘤学和功能结局数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transanal minimally invasive surgery (TAMIS) has gained worldwide popularity as a method for the local excision of rectal neoplasms. However, it is technically demanding due to limited working space. Robotic TAMIS offers potential enhanced dexterity and ability while allowing for a more aggressive resection with a stable platform. The objective of this study was to review a single institution experience between laparoscopic (L-TAMIS) and robotic TAMIS (R-TAMIS) for treatment of rectal neoplasms and determine if there are significant differences on outcomes. METHODS: Forty consecutive patients with rectal neoplasms underwent L-TAMIS or R-TAMIS by two colorectal surgeons from January 2012 to April 2017. We retrospectively reviewed a prospectively maintained database to analyze demographics, peri-operative data, pathology, post-operative complications, and cost. RESULTS: There were no significant differences between L- and R-TAMIS on patient demographics. R-TAMIS showed a statically significant increase in cost of surgery by $880. Median direct cost of L-TAMIS was $3562 compared to $4440.92 for R-TAMIS (p = 0.04). Wider range of total duration for L-TAMIS is likely due to the variability of body habitus and location of rectal neoplasm, which can significantly limit L-TAMIS compare to R-TAMIS. There was a trend toward decreased blood loss in the R-TAMIS group. Mortality was 0% in both groups. CONCLUSIONS: After reviewing our experience, we conclude there is no significant difference between L- and R-TAMIS other than total direct cost. We confirmed that both L- and R-TAMIS are safe and associated with low morbidity. The limitations of this study include its small sample size. In the future, we hope to show promising data on R-TAMIS with increased sample size and experience, which may allow for transanal resection not previously feasible. Studies with long-term follow-up assessing oncological and functional results will be mandatory.
引用
- Lee SG, Russ AJ, Casillas MA, et al. Laparoscopic transanal minimally invasive surgery (L-TAMIS) versus robotic TAMIS (R-TAMIS): short-term outcomes and costs of a comparative study. Surg Endosc. 2018. PMID: 30547391. doi:10.1007/s00464-018-6502-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。